Prevention of atrial fibrillation with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
Adam
Oliver
O
Klinik für Innere Medizin III, Kardiologie, Angiologie und Internistische Intensivmedizin, Universitätsklinikum des Saarlandes, 66424 Homburg/Saar, Germany. o.adam@freenet.de
Neuberger
Hans-Ruprecht
HR
Böhm
Michael
M
Laufs
Ulrich
U
D000818:Animals; D001281:Atrial Fibrillation / Q000201:enzymology* / Q000517:prevention & control*; D002986:Clinical Trials as Topic / Q000379:methods; D006801:Humans; D006903:Hydroxymethylglutaryl CoA Reductases / Q000378:metabolism; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006903:Hydroxymethylglutaryl CoA Reductases